Tevogen TVGN
NASDAQ TVGN
$6.53 -0.17 (-2.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Tevogen (TVGN) Asset Utilization Ratio (2024 - 2026)

Updated

Analysis

Tevogen (TVGN) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 0.62
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 0.50
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 0.47
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 0.52
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 0.46
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 0.51
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 0.40
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 0.58
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 0.31
10 Tevogen 27.79 Mn 27.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.05
Dec 31, 2025 -0.04
Sep 30, 2025 -0.03
Jun 30, 2025 -0.02
Mar 31, 2025 -0.01
Dec 31, 2024 -0.08
API Access

Tevogen Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TVGN&period=max&api_key=YOUR_API_KEY